Compare
MGP Ingredients Inc vs Weyco Group Inc vs Nu Skin Enterprises, Inc. vs Ashland Inc.
| Latest fiscal year | MGP Ingredients Inc MGPI | Weyco Group Inc WEYS | Nu Skin Enterprises, Inc. NUS | Ashland Inc. ASH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $536.38M | $276.17M | $1.49B | $1.82B |
| Revenue growth (YoY) | -23.8% | -4.9% | -14.3% | -13.7% |
| Gross margin | 37.2% | 43.2% | 69.4% | 30.1% |
| Operating margin | -17.6% | 10.6% | 4.4% | -42.5% |
| Net margin | -20.1% | 8.4% | 10.8% | -46.3% |
| Net income | -$107.81M | $23.08M | $160.20M | -$845.00M |
| EPS (Diluted) | -$4.99 | $2.41 | $3.18 | -$18.23 |
| Operating cash flow | $121.53M | $37.25M | $80.29M | $134.00M |
| Free cash flow | $76.04M | $35.50M | $46.01M | $36.00M |
| Cash & equivalents | $18.46M | $96.01M | $238.63M | $215.00M |
| Total assets | $1.24B | $319.67M | $1.41B | $4.61B |
| Total liabilities | $519.07M | $80.10M | $600.07M | n/a |
| Shareholders' equity | $718.44M | $239.57M | $805.24M | $1.90B |
| Return on year-end equity | -15.0% | 9.6% | 19.9% | -44.4% |
| Shares outstanding | 21.29M | 9.53M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | MGP Ingredients Inc | Weyco Group Inc | Nu Skin Enterprises, Inc. | Ashland Inc. |
|---|---|---|---|---|
| Latest | $536.38M Ended 2025-12-31 | $276.17M Ended 2025-12-31 | $1.49B Ended 2025-12-31 | $1.82B Ended 2025-09-30 |
| 1 year earlier | $703.62M Ended 2024-12-31 | $290.29M Ended 2024-12-31 | $1.73B Ended 2024-12-31 | $2.11B Ended 2024-09-30 |
| 2 years earlier | $836.52M Ended 2023-12-31 | $318.05M Ended 2023-12-31 | $1.97B Ended 2023-12-31 | $2.19B Ended 2023-09-30 |
| 3 years earlier | $782.36M Ended 2022-12-31 | $351.74M Ended 2022-12-31 | $2.23B Ended 2022-12-31 | $2.39B Ended 2022-09-30 |
| 4 years earlier | $626.72M Ended 2021-12-31 | $267.64M Ended 2021-12-31 | $2.70B Ended 2021-12-31 | $2.11B Ended 2021-09-30 |